L Dal Maso1, M Lise2, P Zambon3, F Falcini4, E Crocetti5, D Serraino6, C Cirilli7, R Zanetti8, M Vercelli9, S Ferretti10, F Stracci11, V De Lisi12, S Busco13, G Tagliabue14, M Budroni15, R Tumino16, A Giacomin17, S Franceschi18. 1. Epidemiology and Biostatistics Unit, Aviano Cancer Center, IRCCS, Aviano; Department of Occupational Health, Section of Medical Statistics, Università degli Studi di Milano, Milan, Italy. Electronic address: epidemiology@cro.it. 2. Epidemiology and Biostatistics Unit, Aviano Cancer Center, IRCCS, Aviano; International Agency for Research on Cancer, Lyon, France. 3. Veneto Cancer Registry, Istituto Oncologico Veneto IRCCS, Padua. 4. Romagna Cancer Registry, Cancer Institute of Romagna (IRST), Meldola. 5. Tuscany Cancer Registry, Cancer Prevention and Research Istitute (ISPO), Florence. 6. Epidemiology and Biostatistics Unit, Aviano Cancer Center, IRCCS, Aviano; Friuli Venezia Giulia Cancer Registry, Direzione Centrale della Sanità, Trieste. 7. Modena Cancer Registry, Policlinico, Modena. 8. Piedmont Cancer Registry, City of Torino, Ospedale S. Giovanni Battista-CPO, Torino. 9. Liguria Cancer Registry, IST/Università di Genova, Genoa. 10. Ferrara Cancer Registry, Università di Ferrara, Ferrara. 11. Umbria Cancer Registry, Università di Perugia, Perugia. 12. Parma Province Cancer Registry, Ospedale di Parma, Parma. 13. Latina Cancer Registry, AUSL Latina, Latina. 14. Lombardia Cancer Registry, Varese Province, Istituto Nazionale Tumori, Milano. 15. Cancer Registry of Sassari, ASL1, Sassari. 16. Cancer Registry and Histopathology Unit, Department of Oncology, 'Civile M.P.Arezzo' Hospital, ASP 7, Ragusa. 17. Registro Tumori Piemonte, Provincia di Biella (CPO), Biella, Italy. 18. International Agency for Research on Cancer, Lyon, France.
Abstract
BACKGROUND: In Italy, some of the highest incidence rates (IRs) of thyroid cancer (TC) worldwide have been reported. PATIENTS AND METHODS: TC cases <85 years of age reported to Italian cancer registries during 1991-2005 were included. Age-standardized IRs were computed for all TC and age-period-cohort effects were estimated for papillary TC. RESULTS: IRs of TC were twofold higher in 2001-2005 than in 1991-1995 (18 and 8 per 100,000 women, 6 and 3 per 100,000 men, respectively). Increases were similar in the two sexes and nearly exclusively due to papillary TC. Increases of papillary TC by birth cohort were found in both sexes and among all age groups between 20 and 79 years. Age-period-cohort models showed a strong period effect in both sexes (rate ratio for 2001-2009 versus 1991-1995 = 2.5 in women and 2.3 in men), although IRs peaked at an earlier age in women (45-49 years) than men (65-69 years). CONCLUSION: The strength of the period effect in both sexes and the earlier onset in women than men strongly implicated increased medical surveillance in the upward trends of papillary TC incidence in Italy. The consequences of the current intense search for TC on morbidity and possible overtreatment, especially among young women, should be carefully evaluated.
BACKGROUND: In Italy, some of the highest incidence rates (IRs) of thyroid cancer (TC) worldwide have been reported. PATIENTS AND METHODS: TC cases <85 years of age reported to Italian cancer registries during 1991-2005 were included. Age-standardized IRs were computed for all TC and age-period-cohort effects were estimated for papillary TC. RESULTS: IRs of TC were twofold higher in 2001-2005 than in 1991-1995 (18 and 8 per 100,000 women, 6 and 3 per 100,000 men, respectively). Increases were similar in the two sexes and nearly exclusively due to papillary TC. Increases of papillary TC by birth cohort were found in both sexes and among all age groups between 20 and 79 years. Age-period-cohort models showed a strong period effect in both sexes (rate ratio for 2001-2009 versus 1991-1995 = 2.5 in women and 2.3 in men), although IRs peaked at an earlier age in women (45-49 years) than men (65-69 years). CONCLUSION: The strength of the period effect in both sexes and the earlier onset in women than men strongly implicated increased medical surveillance in the upward trends of papillary TC incidence in Italy. The consequences of the current intense search for TC on morbidity and possible overtreatment, especially among young women, should be carefully evaluated.
Authors: N Slijepcevic; V Zivaljevic; I Paunovic; A Diklic; Perisic Zivkovic; D Miljus; A Grgurevic; S Sipetic Journal: Hippokratia Date: 2016 Jan-Mar Impact factor: 0.471
Authors: F Cecoli; E M Ceresola; V Altrinetti; M Cabria; M Cappagli; A Montepagani; C M Cuttica; U Filippi; D Saverino; M Raffa; M Caputo; F Minuto; M Giusti; M Bagnasco Journal: Eur Thyroid J Date: 2016-06-02
Authors: Abdul K Siraj; Tariq Masoodi; Rong Bu; Shaham Beg; Saif S Al-Sobhi; Fouad Al-Dayel; Mohammed Al-Dawish; Fowzan S Alkuraya; Khawla S Al-Kuraya Journal: Am J Hum Genet Date: 2016-05-26 Impact factor: 11.025